[1] Donaldson SS. Rhabdomyosarcoma: contemporary status and future directions. The Lucy Wortham James Clinical Research Award[J]. Arch Surg, 1989,124(9):1015-1020.
[2] Andrade CR, Takahama Junior A, Nishimoto IN, et al. Rhabdomyosarcoma of the head and neck: a clinicopathological and immunohistochemical analysis of 29 cases[J]. Braz Dent J, 2010,21(1):68-73.
[3] Moretti G, Guimaraes R, Oliverira KM, et al. Rhabdomyosarcoma of the head and neck: 24 cases and literature review[J]. Braz J Otorhinolaryngol, 2010,76(4):533-537.
[4] Chigurupati R, Alfatooni A, Myall RW, et al. Orofacial rhabdomyosarcoma in neonates and young children: a review of literature and management of four cases[J]. Oral Oncol, 2002, 38(5):508-515.
[5] Duraes GV, Jham BC, Mesquita ATM, et al. Oral embryonal rhabdomyosarcoma in a child: a case report with immunohistochemical analysis[J]. Oral Oncology Extra, 2006, 42(3):105-108.
[6] Barnes L, John W. Eveson Peter Reichart等. 头颈部肿瘤病理学及遗传学[M]. 北京:人民卫生出版社,2006:335-335.
[7] 李玉林,文继舫,唐建武.病理学[M]. 7版.北京:人民卫生出版社,2012:96-97.
[8] Tonin PN, Scrable H, Shimada H, et al. Muscle-specific gene expression in thabdomyosarcomas and stages of human fetal skeletal muscle development[J]. Cancer Res, 1991, 51(19):5100-5106.
[9] Folpe AL, Patterson K, Gown AM. Antibodies to desmin identify the blastemal component of nephroblastoma[J]. Mod Pathol, 1997, 10(9):895-900.
[10] Géraud C, Koenen W, Neumayr L, et al. Lip cancer: retrospective analysis of 181 cases[J]. J Dtsch Dermatol Ges, 2012, 10(2):121-127.
[11] Wurm J, Constantinidis J, Grabenbauer GG, et al. Rhabdomyosarcomas of the nose and paranasal sinuses: treatment results in 15 cases[J]. Otolaryngol Head Neck Surg, 2005, 133(1):42-50.
[12] 邱蔚六,张震康. 口腔颌面外科学[M]. 5版. 北京:人民卫生出版社, 2003:264-265.
[13] Simon JH, Pau lino AC, Smith RB, et al. Prognostic factors in head and neck rhabdomyosarcoma[J]. Head Neck, 2002, 24(5):468-473. |